Search Count: 40
 |
Crystal Structure Of Histidine Racemase (Hisr) Of Fusobacterium Nucleatum (C67S)
Organism: Fusobacterium nucleatum
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2025-03-05 Classification: ISOMERASE Ligands: SO4 |
 |
Crystal Structure Of Histidine Racemase (Hisr) Of Fusobacterium Nucleatum (C209S)
Organism: Fusobacterium nucleatum
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2025-03-05 Classification: ISOMERASE Ligands: PO4 |
 |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-12-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTM |
 |
Structure Of Sars-Cov2 3Cl Protease Covalently Bound To Peptidomimetic Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-07-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: YWJ, FN7 |
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTJ |
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTP |
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XU4 |
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XV4 |
 |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-05-12 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: UED, EDO, CA |
 |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-05-12 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: EDO, UED |
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor Ligands: K36 |
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor Ligands: UED |
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor |
 |
Organism: Staphylococcus aureus (strain bovine rf122 / et3-1)
Method: SOLUTION NMR Release Date: 2016-08-31 Classification: STRUCTURE FROM CYANA 2.1 |
 |
Organism: Staphylococcus aureus
Method: SOLUTION NMR Release Date: 2016-08-31 Classification: Virulence Factor |
 |
Organism: Staphylococcus aureus
Method: SOLUTION NMR Release Date: 2016-08-31 Classification: SIGNALING PROTEIN |
 |
Organism: Staphylococcus aureus
Method: SOLUTION NMR Release Date: 2016-02-17 Classification: ANTIMICROBIAL PROTEIN |
 |
Organism: Lactococcus lactis
Method: SOLUTION NMR Release Date: 2016-02-17 Classification: ANTIMICROBIAL PROTEIN |